Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Napco Security Technologies
NSSC
$1.37B
| $3.26M | ﹤0.01% |
+94,100
| New | +$3.29M |
|
1677
Novavax
NVAX
$1.34B
| $3.26M | ﹤0.01% |
438,883
-3,101,500
| -88% | -$24.4M |
|
1678
Hanmi Financial
HAFC
$963M
| $3.25M | ﹤0.01% |
217,581
+19,601
| +10% | +$313K |
|
1679
Silgan Holdings
SLGN
$4.46B
| $3.24M | ﹤0.01% |
69,103
-114,172
| -62% | -$5.55M |
|
|
OSG
1680
Octave Specialty Group
OSG
$212M
| $3.22M | ﹤0.01% |
226,344
+144,500
| +177% | +$2.11M |
|
1681
Red Robin
RRGB
$183M
| $3.22M | ﹤0.01% |
232,766
-45,400
| -16% | -$609K |
|
1682
Douglas Emmett
DEI
$1.99B
| $3.22M | ﹤0.01% |
+256,000
| New | +$3.09M |
|
|
PFSW
1683
DELISTED
PFSweb, Inc.
PFSW
| $3.21M | ﹤0.01% |
710,110
-74,800
| -10% | -$312K |
|
1684
Taboola.com
TBLA
$1.06B
| $3.21M | ﹤0.01% |
1,030,899
+461,199
| +81% | +$1.26M |
|
1685
Ranger Energy Services
RNGR
$405M
| $3.21M | ﹤0.01% |
312,990
+121,942
| +64% | +$1.37M |
|
1686
Xencor
XNCR
$1.71B
| $3.2M | ﹤0.01% |
128,273
+16,273
| +15% | +$443K |
|
|
HT
1687
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $3.2M | ﹤0.01% |
525,562
+218,662
| +71% | +$1.34M |
|
1688
DMC Global
BOOM
$153M
| $3.2M | ﹤0.01% |
180,168
+94,700
| +111% | +$1.71M |
|
1689
Fate Therapeutics
FATE
$294M
| $3.2M | ﹤0.01% |
672,316
-660,603
| -50% | -$3.65M |
|
1690
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.2B
| $3.2M | ﹤0.01% |
115,700
+68,900
| +147% | +$1.84M |
|
|
TGNA
1691
DELISTED
TEGNA Inc
TGNA
| $3.19M | ﹤0.01% |
+196,700
| New | +$3.21M |
|
1692
Gentherm
THRM
$1.32B
| $3.19M | ﹤0.01% |
56,464
+36,600
| +184% | +$2.11M |
|
1693
Orrstown Financial Services
ORRF
$855M
| $3.19M | ﹤0.01% |
166,599
-3,200
| -2% | -$59.5K |
|
|
ALLK
1694
DELISTED
Allakos
ALLK
| $3.19M | ﹤0.01% |
730,911
+43,537
| +6% | +$196K |
|
1695
Acadia Realty Trust
AKR
$2.86B
| $3.19M | ﹤0.01% |
221,401
-25,600
| -10% | -$345K |
|
1696
Erasca
ERAS
$6.25B
| $3.18M | ﹤0.01% |
1,151,700
-305,990
| -21% | -$872K |
|
|
TPC
1697
Tutor Perini Cor
TPC
$4.98B
| $3.18M | ﹤0.01% |
444,580
-86,200
| -16% | -$514K |
|
|
EARN
1698
Ellington Residential Mortgage REIT
EARN
$167M
| $3.17M | ﹤0.01% |
440,000
+5,400
| +1% | +$38.4K |
|
1699
Reynolds Consumer Products
REYN
$5.55B
| $3.17M | ﹤0.01% |
112,300
+26,600
| +31% | +$740K |
|
1700
Genius Sports
GENI
$2.2B
| $3.17M | ﹤0.01% |
511,500
-125,600
| -20% | -$630K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.